Real-World data on 3,000 cancer patients could transform oral drug monitoring
NCT ID NCT06317389
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 40 times
Summary
This study follows 3,000 adult cancer patients who take oral anticancer drugs at home, outside the hospital. Researchers want to understand how well these drugs work in real life, what problems patients face, and how a special monitoring program called Oncoral can help. The goal is to improve safety, reduce side effects, and make sure patients get the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Groupement Hospitalier Sud - Unité de Pharmacie Clinique Oncologique
RECRUITINGPierre-Bénite, 69495, France
Contact
Contact
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better manage oral cancer drugs, reduce side effects, and improve treatment outcomes for patients.
What could go wrong
This is an observational study, not a treatment trial. It collects data but does not test a new drug or therapy, so direct patient benefits may take years to emerge.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.